abnormal xenobiotic pharmacokinetics_Slc22a1<tm1Ahs>/Slc22a1<tm1Ahs>

http://metadb.riken.jp/0008875I129P2OlaHsdFVBSlc22a1tm1AhsSlc22a1tm1AhsSlc22a1tm1Ahs

abnormal xenobiotic pharmacokinetics_Slc22a1<tm1Ahs>/Slc22a1<tm1Ahs>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• solute carrier family 22 (organic cation transporter), member 1
  http://metadb.riken.jp/db/mgi_rdf/MGI:108111

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Slc22a1<tm1Ahs>/Slc22a1<tm1Ahs>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Slc22a1<tm1Ahs>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129P2/OlaHsd * FVB

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• abnormal xenobiotic pharmacokinetics
  http://purl.obolibrary.org/obo/MP_0008875

文献

http://purl.org/net/cito/citesAsAuthority

• J W. Jonker, et.al., Reduced hepatic uptake and intestinal excretion of organic cations in mice with a targeted disruption of the organic cation transporter 1 (Oct1 [Slc22a1]) gene., Molecular and cellular biology, 2001, 21
  http://rdf.ncbi.nlm.nih.gov/pubmed/11463829